Bioharvest Sciences Performance
| CNVCFDelisted Stock | USD 5.13 0.07 1.35% |
The firm shows a Beta (market volatility) of 0.16, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Bioharvest Sciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Bioharvest Sciences is expected to be smaller as well. At this point, Bioharvest Sciences has a negative expected return of -0.76%. Please make sure to confirm Bioharvest Sciences' total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to decide if Bioharvest Sciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Bioharvest Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 1.8 M | |
| Total Cashflows From Investing Activities | -1.6 M |
Bioharvest |
Bioharvest Sciences Relative Risk vs. Return Landscape
If you would invest 620.00 in Bioharvest Sciences on December 23, 2024 and sell it today you would lose (107.00) from holding Bioharvest Sciences or give up 17.26% of portfolio value over 90 days. Bioharvest Sciences is currently producing negative expected returns and takes up 2.3225% volatility of returns over 90 trading days. Put another way, 20% of traded otc stocks are less volatile than Bioharvest, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Bioharvest Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioharvest Sciences' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Bioharvest Sciences, and traders can use it to determine the average amount a Bioharvest Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.3273
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CNVCF |
Estimated Market Risk
| 2.32 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.76 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.33 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bioharvest Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bioharvest Sciences by adding Bioharvest Sciences to a well-diversified portfolio.
Bioharvest Sciences Fundamentals Growth
Bioharvest OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Bioharvest Sciences, and Bioharvest Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bioharvest OTC Stock performance.
| Return On Equity | -63.64 | |||
| Return On Asset | -0.53 | |||
| Profit Margin | (2.69) % | |||
| Operating Margin | (2.45) % | |||
| Current Valuation | 106.97 M | |||
| Shares Outstanding | 460.72 M | |||
| Price To Book | 91.96 X | |||
| Price To Sales | 28.13 X | |||
| Revenue | 2.1 M | |||
| EBITDA | (8.63 M) | |||
| Cash And Equivalents | 1.21 M | |||
| Total Debt | 3.97 M | |||
| Debt To Equity | 1.62 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (6.79 M) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 10.21 M | |||
About Bioharvest Sciences Performance
By analyzing Bioharvest Sciences' fundamental ratios, stakeholders can gain valuable insights into Bioharvest Sciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bioharvest Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bioharvest Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product and medical cannabis. Canna-V-Cell Sciences is traded on OTC Exchange in the United States.Things to note about Bioharvest Sciences performance evaluation
Checking the ongoing alerts about Bioharvest Sciences for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Bioharvest Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bioharvest Sciences is not yet fully synchronised with the market data | |
| Bioharvest Sciences generated a negative expected return over the last 90 days | |
| Bioharvest Sciences has a very high chance of going through financial distress in the upcoming years | |
| Bioharvest Sciences has accumulated 3.97 M in total debt with debt to equity ratio (D/E) of 1.62, which is about average as compared to similar companies. Bioharvest Sciences has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Bioharvest Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Bioharvest Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioharvest Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioharvest to invest in growth at high rates of return. When we think about Bioharvest Sciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 2.1 M. Net Loss for the year was (9.83 M) with profit before overhead, payroll, taxes, and interest of 670 K. | |
| Bioharvest Sciences has accumulated about 1.21 M in cash with (6.79 M) of positive cash flow from operations. | |
| Roughly 35.0% of Bioharvest Sciences shares are held by company insiders |
- Analyzing Bioharvest Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bioharvest Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Bioharvest Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bioharvest Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bioharvest Sciences' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Bioharvest Sciences' otc stock. These opinions can provide insight into Bioharvest Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Bioharvest Sciences information on this page should be used as a complementary analysis to other Bioharvest Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Bioharvest OTC Stock
If you are still planning to invest in Bioharvest Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bioharvest Sciences' history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |